2024-09-16 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MYGN |
Sell
All
|
2.3% |
Assets Rebalanced
None
2024-09-13 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.32% |
-2.15% |
2024-09-09 |
The percentage of cash held in the portfolio is:
90.68%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
NVCR |
Sell
All
|
-3.99% |
Assets Rebalanced
None
2024-09-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NVCR
NovoCure Limited
|
Buy |
9.12% |
-6.37% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.55% |
0.26% |
2024-09-09 |
The percentage of cash held in the portfolio is:
81.33%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
TVTX |
Sell
All
|
33.75% |
Assets Rebalanced
None
2024-09-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TVTX
Travere Therapeutics, Inc.
|
Buy |
13.14% |
33.96% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
8.97% |
-7.98% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.6% |
0.63% |
2024-09-09 |
The percentage of cash held in the portfolio is:
68.29%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ALDX |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-09-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TVTX
Travere Therapeutics, Inc.
|
Buy |
11.39% |
14.37% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
9.59% |
-3.01% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
9.25% |
-6.48% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.68% |
0% |
2024-09-09 |
The percentage of cash held in the portfolio is:
60.08%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
MGNX |
Sell
All
|
-7.41% |
ESPR |
Sell
All
|
-9.84% |
Assets Rebalanced
None
2024-09-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MGNX
MacroGenics, Inc.
|
Buy |
9.58% |
-3.7% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.35% |
-6.01% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
10.24% |
3.44% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
9.83% |
0% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
9.83% |
0% |
2024-09-06 |
The percentage of cash held in the portfolio is:
51.17%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MGNX
MacroGenics, Inc.
|
Buy |
9.36% |
-5.41% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.84% |
-0.55% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
10.31% |
4.69% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
9.78% |
0% |
2024-09-05 |
The percentage of cash held in the portfolio is:
60.7%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
PODD |
Sell
All
|
3.96% |
EGRX |
Sell
All
|
-11.35% |
Assets Rebalanced
None
2024-09-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
10.17% |
1.11% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
9.02% |
-10.38% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.31% |
-6.55% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.97% |
0% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.92% |
0% |
2024-09-04 |
The percentage of cash held in the portfolio is:
51.61%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
NEOG |
Sell
All
|
-6.34% |
Assets Rebalanced
None
2024-09-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NEOG
Neogen Corporation
|
Buy |
9.97% |
0.35% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
9.78% |
-0.81% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
9.75% |
-1.15% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.76% |
0% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.76% |
0% |
2024-09-02 |
The percentage of cash held in the portfolio is:
50.98%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CERS |
Sell
All
|
NA |
AADI |
Sell
All
|
NA |
Assets Rebalanced
None
2024-09-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CERS
Cerus Corporation
|
Buy |
9.42% |
-5.04% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.26% |
3.43% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
9.97% |
0.35% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
9.78% |
-0.81% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
9.75% |
-1.15% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.76% |
0% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.76% |
0% |
2024-09-02 |
The percentage of cash held in the portfolio is:
31.29%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CERS
Cerus Corporation
|
Buy |
9.55% |
-3.78% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
9.92% |
0% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
9.89% |
-0.41% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
9.89% |
0.36% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
9.93% |
0.77% |
2024-08-29 |
The percentage of cash held in the portfolio is:
50.82%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CARA |
Sell
All
|
2.62% |
AGEN |
Sell
All
|
-8.78% |
Assets Rebalanced
None
2024-08-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.37% |
3.79% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.33% |
-6.58% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
9.39% |
-5.88% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
9.58% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
9.77% |
-2.15% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
9.91% |
0% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
9.91% |
0% |
2024-08-29 |
The percentage of cash held in the portfolio is:
31.74%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ARDX |
Sell
All
|
-3.45% |
APLS |
Sell
All
|
-4.2% |
ORGO |
Sell
All
|
3.53% |
Assets Rebalanced
None
2024-08-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.55% |
-2.35% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.72% |
-0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.16% |
3.89% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.24% |
4.66% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.07% |
2.93% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
9.53% |
-2.52% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
9.38% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
9.78% |
0% |
2024-08-28 |
The percentage of cash held in the portfolio is:
21.57%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.51% |
-0.94% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.6% |
-0.05% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.28% |
7.07% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.36% |
7.87% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.3% |
7.31% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
9.59% |
0% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
9.59% |
0% |
2024-08-27 |
The percentage of cash held in the portfolio is:
30.77%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.4% |
-5.02% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.72% |
-1.79% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.61% |
-2.83% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.9% |
0% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.9% |
0% |
2024-08-23 |
The percentage of cash held in the portfolio is:
51.48%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.8% |
0% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.8% |
0% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.8% |
0% |
2024-08-22 |
The percentage of cash held in the portfolio is:
70.6%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-07 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RMD |
Sell
All
|
5.19% |
Assets Rebalanced
None
2024-08-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RMD
ResMed Inc.
|
Buy |
9.52% |
7.5% |
2024-07-31 |
The percentage of cash held in the portfolio is:
90.48%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CYH |
Sell
All
|
-1.96% |
HQY |
Sell
All
|
-11.82% |
SAVA |
Sell
All
|
95.11% |
SAGE |
Sell
All
|
-12.65% |
HCSG |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-07-31 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
10.16% |
1.38% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
9.7% |
-3.16% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
11.8% |
17.76% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
9.85% |
-1.73% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
9.73% |
-0.43% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
9.35% |
0% |
2024-07-31 |
The percentage of cash held in the portfolio is:
39.4%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SMTI |
Sell
All
|
-8.69% |
FATE |
Sell
All
|
-7.9% |
CLDX |
Sell
All
|
-12.36% |
Assets Rebalanced
None
2024-07-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
FATE
Fate Therapeutics, Inc.
|
Buy |
9.53% |
-2.87% |
2024-07-24 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
9.39% |
-4.26% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
9.27% |
-5.45% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
9.98% |
1.77% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
9.64% |
-1.69% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
11.85% |
20.78% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
9.65% |
-1.64% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
9.57% |
0% |
2024-07-30 |
The percentage of cash held in the portfolio is:
21.13%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
PTGX |
Sell
All
|
-7.35% |
Assets Rebalanced
None
2024-07-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
FATE
Fate Therapeutics, Inc.
|
Buy |
9.61% |
-2.33% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
9.47% |
-3.84% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
10% |
1.6% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
9.85% |
0% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
9.85% |
0% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
9.85% |
0% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
9.85% |
0% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
9.85% |
0% |
2024-07-29 |
The percentage of cash held in the portfolio is:
21.69%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
FATE
Fate Therapeutics, Inc.
|
Buy |
9.54% |
-3.05% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
9.76% |
-0.76% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
9.84% |
0% |
2024-07-26 |
The percentage of cash held in the portfolio is:
70.86%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
FATE
Fate Therapeutics, Inc.
|
Buy |
9.18% |
-7% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
9.87% |
0% |
2024-07-25 |
The percentage of cash held in the portfolio is:
80.95%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-24 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
FATE
Fate Therapeutics, Inc.
|
Buy |
9.8% |
0% |
2024-07-24 |
The percentage of cash held in the portfolio is:
90.2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-22 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VCYT |
Sell
All
|
-8.31% |
Assets Rebalanced
None
2024-07-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VCYT
Veracyte, Inc.
|
Buy |
9.34% |
-5.34% |
2024-07-18 |
The percentage of cash held in the portfolio is:
90.66%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
WST |
Sell
All
|
-5.09% |
ANGO |
Sell
All
|
13.38% |
CYH |
Sell
All
|
1.62% |
TDOC |
Sell
All
|
-0.64% |
SGRY |
Sell
All
|
13.89% |
AVNS |
Sell
All
|
5.95% |
Assets Rebalanced
None
2024-07-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
WST
West Pharmaceutical Services, Inc.
|
Buy |
8.94% |
-1.88% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
11% |
20.72% |
2024-07-12 |
CYH
Community Health Systems, Inc.
|
Buy |
9.67% |
6.2% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
9.75% |
7.04% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
10.54% |
15.66% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
9.74% |
6.89% |
2024-07-12 |
VCYT
Veracyte, Inc.
|
Buy |
9.59% |
0% |
2024-07-18 |
The percentage of cash held in the portfolio is:
30.77%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
BHVN |
Sell
All
|
0.3% |
PDSB |
Sell
All
|
13.92% |
ALT |
Sell
All
|
0.13% |
OPK |
Sell
All
|
7.58% |
Assets Rebalanced
None
2024-07-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.58% |
10.23% |
2024-07-11 |
BHVN
Biohaven Ltd.
|
Buy |
10.07% |
4.89% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
9.85% |
2.67% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
9.96% |
3.79% |
2024-07-11 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
9.59% |
0% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
9.59% |
0% |
2024-07-12 |
CYH
Community Health Systems, Inc.
|
Buy |
9.59% |
0% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
9.59% |
0% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
9.59% |
0% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
9.59% |
0% |
2024-07-12 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
- WST
- ANGO
- CYH
- TDOC
- SGRY
- AVNS
Assets Removed
None
Assets Rebalanced
None
2024-07-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
9.8% |
0% |
2024-07-11 |
BHVN
Biohaven Ltd.
|
Buy |
9.8% |
0% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
9.8% |
0% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
9.8% |
0% |
2024-07-11 |
The percentage of cash held in the portfolio is:
60.8%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-09 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VERU |
Sell
All
|
-3.41% |
NVRO |
Sell
All
|
-2.79% |
VRDN |
Sell
All
|
-6.81% |
RYTM |
Sell
All
|
2.55% |
Assets Rebalanced
None
2024-07-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NVRO
Nevro Corp.
|
Buy |
10.18% |
-2.67% |
2024-07-02 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
9.7% |
-7.27% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
10% |
-4.36% |
2024-07-02 |
VERU
Veru Inc.
|
Buy |
10.82% |
3.41% |
2024-07-02 |
The percentage of cash held in the portfolio is:
59.3%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CYH |
Sell
All
|
NA |
Assets Rebalanced
None